Felbamate
- Generic Name
- Felbamate
- Brand Names
- Felbatol
- Drug Type
- Small Molecule
- Chemical Formula
- C11H14N2O4
- CAS Number
- 25451-15-4
- Unique Ingredient Identifier
- X72RBB02N8
- Background
Felbamate is an anticonvulsant drug used in the treatment of epilepsy. In particular, in the adult patient population, it can be employed to treat partial seizures (with and without generalization). Alternatively, it is used to treat partial and generalized seizures associated with Lennox-Gastaut syndrome in children. It has a weak inhibitory effect on GABA ...
- Indication
For use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use.
- Associated Conditions
- Refractory Partial Onset Seizures, Status Epilepticus, Refractory Lennox-Gastaut syndrome
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath